Isn’t AMF fighting against this takeover? They’re the second largest shareholder and this deal can only go through if the majority votes yes to the takeover bid.
I’m clearly talking about biotech as a whole. Private equity, and other financial institutions, are looking to invest again. Biotech has seen low investments, this should hopefully turn around with increases in financing.
As soon as that happens, B/B will ‘normalize’ again.
Fortnox is being acquired.
Isn’t AMF fighting against this takeover? They’re the second largest shareholder and this deal can only go through if the majority votes yes to the takeover bid.
we got to wait and see.
”Biotech funding remains robust”… Are you sure lol 😀 Book to bill under 1 at the moment
I’m clearly talking about biotech as a whole. Private equity, and other financial institutions, are looking to invest again. Biotech has seen low investments, this should hopefully turn around with increases in financing.
As soon as that happens, B/B will ‘normalize’ again.